Updates to Endocrine Board Review (EBR) can be found on this page.
Diabetes Mellitus Section 2 Board Review
Michelle Magee
Page(s): 149-171
Update Date: October 8, 2020
Case 42
Original Text: “Octreotide (Answer A), which reduces incretin and insulin secretion, can also be administered; however, its use may be limited by high cost and adverse effects, including diarrhea, steatorrhea, and acute hypoglycemia, most likely due to inhibition of insulin secretion.”
Updated Text: “Octreotide (Answer A), which reduces incretin and insulin secretion, can also be administered; however, its use may be limited by high cost and adverse effects, including diarrhea, steatorrhea, and acute hyperglycemia, most likely due to inhibition of insulin secretion.”
Adrenal Board Review
Tobias Else
Page(s): 7-17
Update Date: August 26, 2020
Case 19
Original Text: “The mass measures 3.4 cm in diameter, the precontrast attenuation value is -5 Hounsfield units, and there is more than 60% contrast medium 15 minutes after contrast administration.”
Updated Text: “The mass measures 3.4 cm in diameter, the precontrast attenuation value is -5 Hounsfield units, and there is more than 60% contrast medium washout15 minutes after contrast administration.”
Calcium & Bone Board Review
Natalie Cusano
Page(s): 18-28
Case 2
Original Text: “Magnesium = 2.3 mg/dL (1.5-2.3 mg/dL).”
Updated Text: “Magnesium = 2.3 mEq/L (1.5-2.3 mEq/L).”
Case 5
Original Text: “Magnesium = 1.6 mg/dL (1.5-2.3 mg/dL).”
Updated Text: “Magnesium = 1.6 mEq/L (1.5-2.3 mEq/L).”
Case 25
Original Text: “Magnesium = 1.9 mg/dL (1.5-2.3 mg/dL).”
Updated Text: “Magnesium = 1.9 mEq/L (1.5-2.3 mEq/L).”
Female Reproduction Board Review
Kathryn Martin
Page(s): 53-58
Case 16
Original Text: “A. Increase the estrogen dosage to a 50-mcg patch.”
Updated Text: “A. Increase the estrogen dosage to transdermal E2 0.05 mg.”